- Home
- Domain Parters Vii L P
Insider Trading History of Domain Parters Vii L P
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Domain Parters Vii L P since 2008.
The trader's CIK number is 1374150.
At the time of the last reporting, Domain Parters Vii L P was the 10% Owner of Esperion Therapeutics, Inc.. (stock ticker symbol ESPR).
Also see all insider trading activities at Esperion Therapeutics, Inc..
Note that in the past
DOMAIN PARTERS VII L P also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Esperion Therapeutics, Inc. (ESPR) by Domain Parters Vii L P
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2013 | ESPR | 280,923 | $3,932,922 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Clovis Oncology, Inc. (CLVS) by Domain Parters Vii L P
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2011 | CLVS | 916,058 | $11,908,754 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Zogenix, Inc. (ZGNX) by Domain Parters Vii L P
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2011 | ZGNX | 3,441,304 | $6,882,608 | 0 | $0 | 0 | $0 |
| 2010 | ZGNX | 2,310,589 | $9,242,356 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Orexigen Therapeutics, Inc. (OREX) by Domain Parters Vii L P
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2011 | OREX | 461,265 | $668,834 | 0 | $0 | 0 | $0 |
| 2009 | OREX | 2,024,086 | $15,046,675 | 0 | $0 | 0 | $0 |
| 2008 | OREX | 237,826 | $1,172,482 | 0 | $0 | 0 | $0 |
Insider trading activities at 4 companies by Domain Parters Vii L P:
1. Esperion Therapeutics, Inc. (ESPR)
2. Clovis Oncology, Inc. (CLVS)
3. Zogenix, Inc. (ZGNX)
4. Orexigen Therapeutics, Inc. (OREX)
Table 1. Insider trading of Esperion Therapeutics, Inc. (ESPR) by Domain Parters Vii L P
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2013-07-01 | ESPR | Buy | 280,923 | 14.00 | 3,932,922 |
Table 2. Insider trading of Clovis Oncology, Inc. (CLVS) by Domain Parters Vii L P
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2011-11-21 | CLVS | Buy | 916,058 | 13.00 | 11,908,754 |
Table 3. Insider trading of Zogenix, Inc. (ZGNX) by Domain Parters Vii L P
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2011-09-16 | ZGNX | Buy | 3,441,304 | 2.00 | 6,882,608 |
| 2010-11-29 | ZGNX | Buy | 2,310,589 | 4.00 | 9,242,356 |
Table 4. Insider trading of Orexigen Therapeutics, Inc. (OREX) by Domain Parters Vii L P
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2011-12-22 | OREX | Buy | 461,265 | 1.45 | 668,834 |
| 2009-12-18 | OREX | Buy | 37,461 | 7.50 | 280,957 |
| 2009-12-17 | OREX | Buy | 98,323 | 7.55 | 742,338 |
| 2009-11-24 | OREX | Buy | 49,161 | 6.75 | 331,836 |
| 2009-11-20 | OREX | Buy | 245,808 | 6.93 | 1,703,449 |
| 2009-11-23 | OREX | Buy | 147,484 | 6.93 | 1,022,064 |
| 2009-11-12 | OREX | Buy | 60,960 | 6.90 | 420,624 |
| 2009-11-10 | OREX | Buy | 82,985 | 6.93 | 575,086 |
| 2009-11-11 | OREX | Buy | 52,701 | 6.93 | 365,217 |
| 2009-08-18 | OREX | Buy | 13,553 | 7.73 | 104,764 |
| 2009-08-14 | OREX | Buy | 25,785 | 8.00 | 206,280 |
| 2009-08-17 | OREX | Buy | 62,141 | 7.64 | 474,757 |
| 2009-08-13 | OREX | Buy | 12,782 | 7.85 | 100,338 |
| 2009-08-12 | OREX | Buy | 393,292 | 8.00 | 3,146,336 |
| 2009-08-11 | OREX | Buy | 102,551 | 7.60 | 779,387 |
| 2009-07-23 | OREX | Buy | 639,099 | 7.50 | 4,793,242 |
| 2008-12-09 | OREX | Buy | 237,826 | 4.93 | 1,172,482 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Domain Parters Vii L P
(10% Owner of Esperion Therapeutics, Inc. at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.